Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5410 results
Bicycle, AstraZeneca enter into potential $1bn multitarget collaboration
By PBR Staff Writer
Bicycle Therapeutics and AstraZeneca have agreed a $1bn multi-target collaboration across respiratory, cardiovascular and metabolic diseases.
Drug Research > Drug Discovery & Development > News
Evotec, Merck sign deals to partner on target discovery technologies
Evotec and Merck have signed agreements to collaborate on target discovery technologies.
Drug Research > Drug Discovery & Development > News
OxThera raises EUR32m to complete Oxabact development to treat primary hyperoxaluria
Swedish privately-held biopharmaceutical firm OxThera has raised EUR32m to complete development of Oxabact for the treatment of primary hyperoxaluria.
Drug Research > Drug Discovery & Development > News
Ergomed acquires PharmInvent
Pharmaceutical services and drug development firm Ergomed has acquired European PharmInvent Services s.r.o. (PharmInvent), a European pharmacovigilance and regulatory services business.
Drug Research > Drug Discovery & Development > News
UK biopharmaceutical firm Kymab secures $100m of funding
By PBR Staff Writer
UK-based biopharmaceutical firm Kymab has secured $100m of funding to advance its pipeline of therapeutic human monoclonal antibodies.
Drug Research > Drug Discovery & Development > News
WuXi Biologics, Prima sign non-binding MOU for biologics development
WuXi Biologics, a WuXi AppTec group company, and Prima Biomed have signed a non-binding MOU to form a strategic biologics development and manufacturing partnership.
Drug Research > Drug Discovery & Development > News
Allergan acquires Chase Pharmaceuticals
Allergan has acquired Chase Pharmaceuticals, a clinical-stage biopharmaceutical firm engaged in the development of improved treatments for neurodegenerative disorders including Alzheimer's disease (AD).
Drug Research > Drug Discovery & Development > News
Chemoswed Receives CEP Approval for Benserazide HCl
Chemoswed now officially holds a CEP for benserazide hydrochloride, the latest addition to it’s commercial range of products
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed Acquired by Magle AB
Chemoswed is now a part of the Magle Chemoswed group
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed: Commercial Scale Manufacture of Benserazide Hydrochloride in Main Plant
Chemoswed announces that commercial scale manufacture of benserazide hydrochloride has now been established in the main plant.
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed Reports Successful USFDA Audit
Chemoswed is regularly inspected and certified by the Swedish Medical Products Agency. Additionally, late last year, the facilities were audited by the US Food and Drug Administration during a week-long onsite inspection
Drug Research > Drug Discovery & Development > Press Releases
Chemoswed Renewed GMP Certificate
Following inspections which took place late 2014, Chemoswed has received an updated certificate of GMP compliance.
Drug Research > Drug Discovery & Development > Press Releases
FDA scientists develop new mouse model for Zika studies
Scientists at the US Food and Drug Administration (FDA) have developed a new mouse model which may help in exploring the potential activity of Zika virus vaccines and therapeutics.
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Hybrigenics Services - Protein Interactions Expert
Who else knows your protein better than you? Who else knows proteins interactions better than us?... Drug Research > Drug Discovery & Development > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Drug Research > Drug Discovery & Development > Suppliers
Chemoswed - Suppliers of Active Pharmaceutical Ingredients
Chemoswed is the reliable Swedish custom synthesis specialist, supplying active ingredients since 1944. With a background in Pharmacia, Chemoswed is since 1996 an independent entity within the DuPont group, offering cost-effective, turn-key solutions to API needs worldwide.We have established unparalleled experience and technology, enabling efficient development and production of quality active pharmaceutical ingredients in quantities from 100 grams to 50 tons.... Drug Research > Drug Discovery & Development > Suppliers
Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products
Novo Nordisk Pharmatech A/S is a Novo Nordisk company that specialises in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as insulin human for cell culture media and cGMP manufactured quaternary ammonium compounds (usually referred to as quats) such as benzalkonium chloride, cetrimide and cetrimonium bromide.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Biovian's Contract Manufacturing of Biopharmaceuticals By Biovian
Biovian is a one-stop-shop in GMP contract manufacturing of biopharmaceuticals covering services from early development to finished vial.... Drug Research > Drug Discovery & Development > White Papers 1.5 Specific dsDNA Quantification UV/VIS-based cDrop™ Method vs Picogreen® Fluorescent Assay By Trinean
Precise quantification and normalization of isolated genomic DNA is critical for advanced molecular testing in life science research and molecular diagnostics. UV-Vis based quantification has long been the method of choice, mainly because of its convenience. However, determining the DNA concentration based on the absorbance at 260nm suffers from interference of components such as RNA, proteins and phenols. Alternative methods, such as the PicoGreen® based Quant-iT™ assay, based on fluorescence enhancement upon binding with dsDNA have been developed to address this issue.... Drug Research > Drug Discovery & Development > White Papers 1.3 Micro-volume Protein Quantification using the DropSense96 Droplet Plate Reader By Trinean
The measurement of protein concentration in aqueous samples is an important assay in biochemistry research and protein production facilities. Spectrophotometric protein quantification assays are commonly used methods to rapidly determine the concentration of a protein. They utilize the direct UV absorbance of the protein at 280nm in combination with its extinction coefficient or an indirect dye-based methods like BCA, Lowry and Bradford assays.... Drug Research > Drug Discovery & Development > White Papers 1.2 DropSense96 and its DropPlates, a Versatile Tool for Nucleic Acid and Protein Droplet Quantification By Trinean
As the demand for molecular tests increases, automated systems for biomolecule isolation and sample analysis are becoming popular. These facilitate integration of the complete molecular test in a full automatic set-up with liquid robots and bar-coded sample tracking resulting in a significant higher throughput while minimizing tedious manual repetitive tasks. The Trinean technology is a unique combination of the DropSense96 droplet plate reader, the 96well DropPlate microfuidic consumables and the DropQuant analytical software enabling direct quantification of small biomolecule samples in these high throughput, automated workflow.... Drug Research > Drug Discovery & Development > White Papers 1.14 Droplet UV/VIS Quantification of Native Proteins in Biopharmaceutical Processing By Trinean
Biopharmaceuticals are mainly produced by microbial fermentation or in animal cell cultures. As a consequence, a cascade of procedures including purification and characterization are required throughout the processing chain to obtain the protein at the desired level of purity and potency. Within these processes, quantification of the protein of interest is mandatory at critical steps to maintain confidence in the processing results and fidelity in the end product.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5410 results